88
Views
1
CrossRef citations to date
0
Altmetric
Original Scientific Papers

Association between anaemia and long-term prognosis in patients with non-ST segment elevation myocardial infarction

&
Pages 179-186 | Received 27 Sep 2023, Accepted 26 Nov 2023, Published online: 12 Dec 2023

References

  • Bhatt DL, Lopes RD, Harrington RA. Diagnosis and treatment of acute coronary syndromes: a review. JAMA. 2022 Feb 15;327(7):662–675. Erratum in: JAMA. 2022 May 3;327(17):1710. doi: 10.1001/jama.2022.0358.
  • Murugiah K, Wang Y, Nuti SV, China PEACE Collaborative Group., et al. Are non-ST-segment elevation myocardial infarctions missing in China? Eur Heart J Qual Care Clin Outcomes. 2017 Oct 1;3(4):319–327. doi: 10.1093/ehjqcco/qcx025.
  • Roffi M, Patrono C, Collet JP, et al. 2015 ESC guidelines for the management of acute coronary syndromes in patients presenting without persistent ST - segment elevation: task force for the management of acute coronary syndromes in patients presenting without persistent ST - segment elevation of the european society of cardiology (ESC) [J]. Eur Heart J. 2016;37(3):267–315. doi: 10.1093/eurheartj/ehv320.
  • Hoole SP, Bambrough P. Recent advances in percutaneous coronary intervention. Heart. 2020;106(18):1380–1386. doi: 10.1136/heartjnl-2019-315707.
  • Femminò S, D’Ascenzo F, Ravera F, et al. Percutaneous coronary intervention (PCI) reprograms circulating extracellular vesicles from ACS patients impairing their Cardio-Protective properties. Int J Mol Sci. 2021 Sep 24;22(19):10270. PMID: 34638611; doi: 10.3390/ijms221910270.
  • Collet JP, Thiele H, Barbato E, et al. ESC guidelines for the management of acute coronary syndromes in patients presenting without persistent ST – segment elevation[J]. Eur Heart J., 2020; 42(20):2020–2021. doi: 10.1093/eurheartj/ehaa909.
  • Nutritional anaemias. Report of a WHO scientific group. Geneva, World Health Organization, 1968. (WHO Technical Report Series, No. 405).
  • Sarnak MJ, Tighiouart H, Manjunath G, et al. Anemia as a risk factor for cardiovascular disease in the atherosclerosis risk in communities (ARIC) study. J Am Coll Cardiol. 2002 Jul 3;40(1):27–33. doi: 10.1016/s0735-1097(02)01938-1. PMID: 12103252.
  • Meneveau N, Schiele F, Seronde MF, et al. Anemia for risk assessment of patients with acute coronary syndromes. Am J Cardiol. 2009;103(4):442–447. doi: 10.1016/j.amjcard.2008.10.023.
  • Pinto de Carvalho L, McCullough PA, Gao F, et al. Renal function and anaemia in acute myocardial infarction. Int J Cardiol. 2013;168(2):1397–1401. doi: 10.1016/j.ijcard.2012.12.017.
  • Anker SD, Voors A, Okonko D, et al. Prevalence, incidence, and prognostic value of anaemia in patients after an acute myocardial infarction: data from the OPTIMAAL trial. Eur Heart J. 2009;30(11):1331–1339. doi: 10.1093/eurheartj/ehp116.
  • Kunadian V, Mehran R, Lincoff AM, et al. Effect of anemia on frequency of short- and long-term clinical events in acute coronary syndromes (from the acute catheterization and urgent intervention triage strategy trial). Am J Cardiol. 2014;114(12):1823–1829. doi: 10.1016/j.amjcard.2014.09.023.
  • Hong YJ, Jeong MH, Choi YH, et al. Relation between anemia and vulnerable coronary plaque components in patients with acute coronary syndrome: virtual histology-intravascular ultrasound analysis. J Korean Med Sci. 2012 Apr;27(4):370–376. doi: 10.3346/jkms.2012.27.4.370.
  • Metivier F, Marchais SJ, Guerin AP, et al. Pathophysiology of anaemia: focus on the heart and blood vessels. Nephrol Dial Transplant. 2000;15 Suppl 3(suppl_3):14–18. doi: 10.1093/oxfordjournals.ndt.a027970.
  • Nikolsky E, Aymong ED, Halkin A, et al. Impact of anemia in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention: analysis from the controlled abciximab and device investigation to lower late angioplasty complications (CADILLAC). J Am Coll Cardiol. 2004;44(3):547–553. doi: 10.1016/j.jacc.2004.03.080.
  • Pilgrim T, Vetterli F, Kalesan B, et al. The impact of anemia on long-term clinical outcome in patients undergoing revascularization with the unrestricted use of drug-eluting stents. Circ Cardiovasc Interv. 2012;5(2):202–210. doi: 10.1161/CIRCINTERVENTIONS.111.965749.
  • Voeltz MD, Patel AD, Feit F, et al. Effect of anemia on hemorrhagic complications and mortality following percutaneous coronary intervention. Am J Cardiol. 2007;99(11):1513–1517. doi: 10.1016/j.amjcard.2007.01.027.
  • Djohan AH, Sia C-H, Loh JP-Y. A focused review on optimal coronary revascularisation in patients with chronic kidney disease. AsiaIntervention. 2019;5(1):32–40. doi: 10.4244/AIJ-D-18-00015.
  • Amsterdam EA, Wenger NK, Brindis RG, et al. AHA/ACC guideline for the management of patients with non-ST-elevation acute coronary syndromes: a report of the American college of cardiology/American heart association task force on practice guidelines. J Am Coll Cardiol. 2014. 2014;64(24):e139–e228. doi: 10.1016/j.jacc.2014.09.017.
  • O’Gara PT, Kushner FG, Ascheim DD, et al. ACCF/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American college of cardiology foundation/American heart association task force on practice guidelines. Circulation. 2013. 2013;127(4):e362–e425.
  • Antman EM, Anbe DT, Armstrong PW, et al. ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction. A report of the American college of cardiology/American heart association task force on practice guidelines (committee to revise the 1999 guidelines for the management of patients with acute myocardial infarction. J Am Coll Cardiol. 2004;44(3):E1–E211.) doi: 10.1016/j.jacc.2004.07.014.
  • Khan AR, Golwala H, Tripathi A, et al. Impact of total occlusion of culprit artery in acute non-ST elevation myocardial infarction: a systematic review and meta-analysis. Eur Heart J. 2017;38(41):3082–3089. doi: 10.1093/eurheartj/ehx418.
  • Bassand JP, Afzal R, Eikelboom J, OASIS 5 and OASIS 6 Investigators., et al. Relationship between baseline haemoglobin and major bleeding complications in acute coronary syndromes. Eur Heart J. 2010;31(1):50–58. doi: 10.1093/eurheartj/ehp401.
  • Mehran R, Pocock SJ, Nikolsky E, et al. A risk score to predict bleeding in patients with acute coronary syndromes. J Am Coll Cardiol. 2010;55(23):2556–2566. doi: 10.1016/j.jacc.2009.09.076.
  • Kunadian V, Mehran R, Lincoff AM, et al. Effect of Anemia on frequency of short- and long-term clinical events in acute coronary syndromes (from the acute catheterization and urgent intervention triage strategy trial). Am J Cardiol. 2014;114:1823–1829.
  • Most AS, Ruocco NA, Jr, Gewirtz H. Effect of a reduction in blood viscosity on maximal myocardial oxygen delivery distal to a moderate coronary stenosis. Circulation. 1986 Nov;74(5):1085–1092. doi: 10.1161/01.cir.74.5.1085.
  • Levy PS, Quigley RL, Gould SA. Acute dilutional anemia and critical left anterior descending coronary artery stenosis impairs end organ oxygen delivery. J Trauma. 1996 Sep;41(3):416–423. doi: 10.1097/00005373-199609000-00006.
  • Rousseau M, Yan RT, Tan M, Integrilin and Enoxaparin Randomized Assessment of Acute Coronary Syndrome Treatment (INTERACT) Trial Investigators., et al. Relation between hemoglobin level and recurrent myocardial ischemia in acute coronary syndromes detected by continuous electrocardiographic monitoring. Am J Cardiol. 2010 Nov 15;106(10):1417–1422. doi: 10.1016/j.amjcard.2010.07.009.
  • Brener SJ, Mehran R, Dangas GD, et al. Relation of baseline hemoglobin levels and adverse events in patients with acute coronary syndromes (from the acute catheterization and urgent intervention triage strategY and harmonizing outcomes with RevasculariZatiON and stents in acute myocardial infarction trials). Am J Cardiol. 2017 Jun 1;119(11):1710–1716. doi: 10.1016/j.amjcard.2017.02.052.
  • Sabatine MS, Morrow DA, Giugliano RP, et al. Association of hemoglobin levels with clinical outcomes in acute coronary syndromes. Circulation. 2005 Apr 26;111(16):2042–2049. doi: 10.1161/01.CIR.0000162477.70955.5F.
  • Lawler PR, Filion KB, Dourian T, et al. Anemia and mortality in acute coronary syndromes: a systematic review and meta-analysis. Am Heart J. 2013 Feb;165(2):143–153.e5. doi: 10.1016/j.ahj.2012.10.024.
  • Liu Y, Yang YM, Zhu J, et al. Anaemia and prognosis in acute coronary syndromes: a systematic review and meta-analysis. J Int Med Res. 2012;40(1):43–55. doi: 10.1177/147323001204000105.
  • Younge JO, Nauta ST, Akkerhuis KM, et al. Effect of anemia on short- and long-term outcome in patients hospitalized for acute coronary syndromes. Am J Cardiol. 2012 Feb 15;109(4):506–510. doi: 10.1016/j.amjcard.2011.09.046.
  • Maluenda G, Lemesle G, Collins SD, et al. The clinical significance of hematocrit values before and after percutaneous coronary intervention. Am Heart J. 2009 Dec;158(6):1024–1030. doi: 10.1016/j.ahj.2009.10.005.
  • Ayhan E, Aycicek F, Uyarel H, et al. Patients with anemia on admission who have undergone primary angioplasty for ST elevation myocardial infarction: in-hospital and long-term clinical outcomes. Coron Artery Dis. 2011;22(6):375–379. doi: 10.1097/MCA.0b013e3283472ac5.
  • Kurek T, Lenarczyk R, Kowalczyk J, et al. Effect of anemia in high-risk groups of patients with acute myocardial infarction treated with percutaneous coronary intervention. Am J Cardiol. 2010 Mar 1;105(5):611–618. doi: 10.1016/j.amjcard.2009.10.036.
  • Greenberg G, Assali A, Vaknin-Assa H, et al. Hematocrit level as a marker of outcome in ST-segment elevation myocardial infarction. Am J Cardiol. 2010 Feb 15;105(4):435–440. doi: 10.1016/j.amjcard.2009.10.016.
  • Uchida Y, Ichimiya S, Ishii H, et al. Impact of admission anemia on coronary microcirculation and clinical outcomes in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention. Int Heart J. 2015;56(4):381–388. Epub 2015 Jun 24. doi: 10.1536/ihj.15-006.
  • Tsujita K, Nikolsky E, Lansky AJ, et al. Impact of anemia on clinical outcomes of patients with ST-segment elevation myocardial infarction in relation to gender and adjunctive antithrombotic therapy (from the HORIZONS-AMI trial). Am J Cardiol. 2010 May 15;105(10):1385–1394. doi: 10.1016/j.amjcard.2010.01.001.
  • Rathod KS, Jones DA, Rathod VS, et al. Prognostic impact of anaemia on patients with ST-elevation myocardial infarction treated by primary PCI. Coron Artery Dis. 2014;25(1):52–59. doi: 10.1097/MCA.0000000000000038.
  • Matsue Y, Matsumura A, Abe M, et al. Prognostic implications of chronic kidney disease and anemia after percutaneous coronary intervention in acute myocardial infarction patients. Heart Vessels. 2013;28(1):19–26. doi: 10.1007/s00380-011-0209-2.
  • Jiang L, Gao Z, Song Y, et al. Impact of anemia on percutaneous coronary intervention in chinese patients: a large single center data. J Interv Cardiol. 2018;31(6):826–833. doi: 10.1111/joic.12570.
  • Kruk M, Przyłuski J, Kalińczuk L, et al. Hemoglobin, leukocytosis and clinical outcomes of ST-elevation myocardial infarction treated with primary angioplasty: ANIN myocardial infarction registry. Circ J. 2009;73(2):323–329.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.